Search results
Pfizer along witth Eli Lilly and Novo Nordisk, enroute to develop their second generation weight...
CNBC TV18· 6 hours agoPfizer plans to move a reworked, once-a-day version of its weight loss pill, danuglipron, into...
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln - ET HealthWorld | Pharma
The Economic Times· 3 days agoLondon: Eli Lilly will acquire Morphic Holding for $3.2 billion in cash, the companies said on...
Pfizer moves forward with once-daily weight loss pill
Clinical Trials Arena· 7 hours agoNovo Nordisk currently dominates the space with its GLP-1 agonist drug Wegovy (semaglutide) which...
Eli Lilly weight loss drug beats Ozempic in head-to-head study - ET HealthWorld | Pharma
The Economic Times· 3 days agoWashington: Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss...
Novo’s once-weekly insulin rejected by FDA
BioPharma Dive· 11 hours agoThe FDA’s decision to turn back the drugmaker’s new insulin product narrows Novo’s lead in the U.S. over Eli Lilly, which has a similar diabetes...
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices - ETPharma
The Economic Times· 14 hours agoWashington: Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal, says report - CNBC TV18
CNBC TV18· 3 days agoLilly counts its IBD drug, Omvoh, among its future growth drivers, besides its blockbuster weight...
Lilly to buy Morphic in $3B bet on inflammation drug
BioPharma Dive· 3 days agoThe deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...
Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition
Pharmaceutical Technology· 3 days agoEli Lilly has signed a definitive agreement to acquire Morphic Holding for $3.2bn, expanding its...
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss - ET...
The Economic Times· 2 days agoLondon: Shares in Novo Nordisk , maker of the wildly popular obesity drug Wegovy, were down 1.1 per...
